Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 264


Circulating miR-423_5p fails as a biomarker for systemic ventricular function in adults after atrial repair for transposition of the great arteries.

Tutarel O, Dangwal S, Bretthauer J, Westhoff-Bleck M, Roentgen P, Anker SD, Bauersachs J, Thum T.

Int J Cardiol. 2013 Jul 15;167(1):63-6. doi: 10.1016/j.ijcard.2011.11.082. Epub 2011 Dec 20.


Assessment of myocardial function of the systemic right ventricle in patients with D-transposition of the great arteries after atrial switch operation by tissue Doppler echocardiography.

Rentzsch A, Abd El Rahman MY, Hui W, Helweg A, Ewert P, Gutberlet M, Lange PE, Berger F, Abdul-Khaliq H.

Z Kardiol. 2005 Aug;94(8):524-31.


microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.

Brunet Vega A, Pericay C, Moya I, Ferrer A, Dotor E, Pisa A, Casalots À, Serra-Aracil X, Oliva JC, Ruiz A, Saigí E.

Oncol Rep. 2013 Jul;30(1):320-6. doi: 10.3892/or.2013.2475. Epub 2013 May 15.


Targeting the circulating microRNA signature of obesity.

Ortega FJ, Mercader JM, Catalán V, Moreno-Navarrete JM, Pueyo N, Sabater M, Gómez-Ambrosi J, Anglada R, Fernández-Formoso JA, Ricart W, Frühbeck G, Fernández-Real JM.

Clin Chem. 2013 May;59(5):781-92. doi: 10.1373/clinchem.2012.195776. Epub 2013 Feb 8.


Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.

Kodahl AR, Lyng MB, Binder H, Cold S, Gravgaard K, Knoop AS, Ditzel HJ.

Mol Oncol. 2014 Jul;8(5):874-83. doi: 10.1016/j.molonc.2014.03.002. Epub 2014 Mar 16.


Circulating microRNAs as biomarkers of adult Crohn's disease.

Jensen MD, Andersen RF, Christensen H, Nathan T, Kjeldsen J, Madsen JS.

Eur J Gastroenterol Hepatol. 2015 Sep;27(9):1038-44. doi: 10.1097/MEG.0000000000000430.


Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers.

van Schooneveld E, Wouters MC, Van der Auwera I, Peeters DJ, Wildiers H, Van Dam PA, Vergote I, Vermeulen PB, Dirix LY, Van Laere SJ.

Breast Cancer Res. 2012 Feb 21;14(1):R34.


Characterization of circulating microRNA expression in patients with a ventricular septal defect.

Li D, Ji L, Liu L, Liu Y, Hou H, Yu K, Sun Q, Zhao Z.

PLoS One. 2014 Aug 28;9(8):e106318. doi: 10.1371/journal.pone.0106318. eCollection 2014.


Circulating microRNA expression profiles associated with systemic lupus erythematosus.

Carlsen AL, Schetter AJ, Nielsen CT, Lood C, Knudsen S, Voss A, Harris CC, Hellmark T, Segelmark M, Jacobsen S, Bengtsson AA, Heegaard NH.

Arthritis Rheum. 2013 May;65(5):1324-34. doi: 10.1002/art.37890.


[Left ventricular function in adult patients after the atrial switch operation for transposition of the great arteries].

Takeuchi D, Nakanishi T, Kondo S, Nakazawa M.

J Cardiol. 2003 Mar;41(3):119-25. Japanese.


Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease.

Tan L, Yu JT, Tan MS, Liu QY, Wang HF, Zhang W, Jiang T, Tan L.

J Alzheimers Dis. 2014;40(4):1017-27. doi: 10.3233/JAD-132144.


Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.

Fang L, Ellims AH, Moore XL, White DA, Taylor AJ, Chin-Dusting J, Dart AM.

J Transl Med. 2015 Sep 24;13:314. doi: 10.1186/s12967-015-0672-0.


Clinical evaluation of microRNA expression profiling in non small cell lung cancer.

Markou A, Sourvinou I, Vorkas PA, Yousef GM, Lianidou E.

Lung Cancer. 2013 Sep;81(3):388-96. doi: 10.1016/j.lungcan.2013.05.007. Epub 2013 Jun 10.


Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma.

Lian F, Cui Y, Zhou C, Gao K, Wu L.

PLoS One. 2015 Mar 16;10(3):e0121499. doi: 10.1371/journal.pone.0121499. eCollection 2015.


Differential expression of plasma microRNA in preeclamptic patients at delivery and 1 year postpartum.

Murphy MS, Casselman RC, Tayade C, Smith GN.

Am J Obstet Gynecol. 2015 Sep;213(3):367.e1-9. doi: 10.1016/j.ajog.2015.05.013. Epub 2015 May 14.


Circulating annexin A5 levels after atrial switch for transposition of the great arteries: relationship with ventricular deformation and geometry.

Lai CT, Chow PC, Wong SJ, Chan KW, Cheung YF.

PLoS One. 2012;7(12):e52125. doi: 10.1371/journal.pone.0052125. Epub 2012 Dec 20.


Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas.

Yang C, Wang C, Chen X, Chen S, Zhang Y, Zhi F, Wang J, Li L, Zhou X, Li N, Pan H, Zhang J, Zen K, Zhang CY, Zhang C.

Int J Cancer. 2013 Jan 1;132(1):116-27. doi: 10.1002/ijc.27657. Epub 2012 Jun 26.


The systemic right ventricle in congenitally corrected transposition of the great arteries is different from the right ventricle in dextro-transposition after atrial switch: a cardiac magnetic resonance study.

Grothoff M, Fleischer A, Abdul-Khaliq H, Hoffmann J, Lehmkuhl L, Luecke C, Gutberlet M.

Cardiol Young. 2013 Apr;23(2):239-47. doi: 10.1017/S1047951112000790. Epub 2012 Jun 14.


Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy.

Roncarati R, Viviani Anselmi C, Losi MA, Papa L, Cavarretta E, Da Costa Martins P, Contaldi C, Saccani Jotti G, Franzone A, Galastri L, Latronico MV, Imbriaco M, Esposito G, De Windt L, Betocchi S, Condorelli G.

J Am Coll Cardiol. 2014 Mar 11;63(9):920-7. doi: 10.1016/j.jacc.2013.09.041. Epub 2013 Oct 23.

Supplemental Content

Support Center